Related Experiment Video
Updated: Feb 27, 2026
09:02
Monitoring Influenza Virus Survival Outside the Host Using Real-Time Cell Analysis
Published on: February 20, 2021
3.5K
[French haemovigilance from 1994 to nowadays: Evolution and prospects]
B Lassale1, G Daurat2, M Besse-Moreau3
1Hémovigilance, AP-HM, 270, boulevard Sainte-Marguerite, 13274 Marseille, cedex 9, France.
Summary
Haemovigilance, established in 1993, monitors the blood transfusion chain, integrating risk management and patient identity verification. It is expanding its role to include training and managing blood products for enhanced safety.
Area of Science:
- Transfusion Medicine
- Public Health
- Risk Management
Background:
- Haemovigilance, originating in France in 1993, systematically monitors the blood transfusion process.
- It is distinguished by its comprehensive data collection and organizational structure within the transfusion chain.
Purpose of the Study:
- To analyze the evolution and expanding roles of haemovigilance.
- To highlight its function in risk management, patient identification, and professional training.
Main Methods:
- Review of haemovigilance practices and organizational development.
- Analysis of its integration into hospital risk management and patient safety protocols.
Main Results:
- Haemovigilance has evolved beyond basic monitoring to include proactive risk assessment (a-priori analysis).
- It plays a crucial role in patient identity monitoring using immunological-hematological data.
- New responsibilities include professional training and implementing patient blood management.
Conclusions:
- Haemovigilance is a critical component of blood transfusion safety, extending into risk prevention and patient identification.
- Its expanding scope necessitates specialized roles, such as the blood transfusion practitioner, and broader oversight of blood-derived products.
Related Concept Videos
01:19Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
01:26Principles of Disease Surveillance
713
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
713
01:13Bioequivalence studies: Biowaivers
332
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
332
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
54
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
54
01:25Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
01:28Biopharmaceutics and Pharmacokinetics: Overview
4.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.6K